Misplaced Pages

Benproperine: Difference between revisions

Article snapshot taken from[REDACTED] with creative commons attribution-sharealike license. Give it a read and then ask your questions in the chat. We can research this topic together.
Browse history interactively
Page 1
Page 2
← Previous editContent deleted Content addedVisualWikitext
Revision as of 15:08, 14 February 2011 editCheMoBot (talk | contribs)Bots141,565 edits Updating {{drugbox}} (no changed fields - added verified revid - updated 'ChEMBL_Ref', 'KEGG_Ref') per Chem/Drugbox validation (report errors or [[user← Previous edit Latest revision as of 21:41, 2 February 2024 edit undoVastV0idInSpace0 (talk | contribs)Extended confirmed users2,431 edits fixed spacing between stub template and category templatesTag: 2017 wikitext editor 
(30 intermediate revisions by 21 users not shown)
Line 1: Line 1:
{{short description|Chemical compound}}
{{drugbox
{{Drugbox
⚫ | verifiedrevid = 413884135
| Watchedfields = changed
⚫ | IUPAC_name = 1-piperidine
⚫ | verifiedrevid = 447813319
| image = benproperine.png
⚫ | IUPAC_name = (''RS'')-1-piperidine
| image = (RS)-Benproperine Enantiomers Formulae V.1.svg
<!--Clinical data-->
| tradename = Blascorid, Pectipront, Pirexyl, Tussafug
| Drugs.com = {{drugs.com|international|benproperine}}
⚫ | pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
⚫ | pregnancy_US = <!-- A / B / C / D / X -->
⚫ | pregnancy_category =
⚫ | legal_AU = <!-- Unscheduled / S2 / S3 / S4 / S5 / S6 / S7 / S8 / S9 -->
⚫ | legal_CA = <!-- / Schedule I, II, III, IV, V, VI, VII, VIII -->
⚫ | legal_UK = <!-- GSL / P / POM / CD / Class A, B, C -->
⚫ | legal_US = <!-- OTC / Rx-only / Schedule I, II, III, IV, V -->
⚫ | legal_status =
⚫ | routes_of_administration =
<!--Pharmacokinetic data-->
⚫ | bioavailability =
⚫ | protein_bound =
⚫ | metabolism =
⚫ | elimination_half-life =
⚫ | excretion =
<!--Identifiers-->
⚫ | CAS_number_Ref = {{cascite|correct|??}}
⚫ | CAS_number = 2156-27-6
⚫ | CAS_supplemental = 19428-14-9 (] salt)
⚫ | ATC_prefix = R05
⚫ | ATC_suffix = DB02
⚫ | PubChem = 2326
| ChEMBL = 2105910
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
⚫ | DrugBank =
⚫ | ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
⚫ | ChemSpiderID = 2236
| UNII_Ref = {{fdacite|correct|FDA}} | UNII_Ref = {{fdacite|correct|FDA}}
| UNII = 3AA6IZ48YK | UNII = 3AA6IZ48YK
| KEGG_Ref = {{keggcite|correct|kegg}} | KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D07512 | KEGG = D07512
<!--Chemical data-->
| InChI = 1/C21H27NO/c1-18(22-14-8-3-9-15-22)17-23-21-13-7-6-12-20(21)16-19-10-4-2-5-11-19/h2,4-7,10-13,18H,3,8-9,14-17H2,1H3
⚫ | C=21 | H=27
| N=1 | O=1
| smiles = O(c1ccccc1Cc2ccccc2)CC(N3CCCCC3)C | smiles = O(c1ccccc1Cc2ccccc2)CC(N3CCCCC3)C
| InChIKey = JTUQXGZRVLWBCR-UHFFFAOYAA
⚫ | CASNo_Ref = {{cascite|correct|??}}
| StdInChI_Ref = {{stdinchicite|correct|chemspider}} | StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C21H27NO/c1-18(22-14-8-3-9-15-22)17-23-21-13-7-6-12-20(21)16-19-10-4-2-5-11-19/h2,4-7,10-13,18H,3,8-9,14-17H2,1H3 | StdInChI = 1S/C21H27NO/c1-18(22-14-8-3-9-15-22)17-23-21-13-7-6-12-20(21)16-19-10-4-2-5-11-19/h2,4-7,10-13,18H,3,8-9,14-17H2,1H3
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}} | StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = JTUQXGZRVLWBCR-UHFFFAOYSA-N | StdInChIKey = JTUQXGZRVLWBCR-UHFFFAOYSA-N
⚫ | CAS_number = 2156-27-6
⚫ | ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
⚫ | ChemSpiderID = 2236
⚫ | CAS_supplemental = 19428-14-9 (] salt)
⚫ | ATC_prefix = R05
⚫ | ATC_suffix = DB02
⚫ | PubChem = 2326
⚫ | DrugBank =
⚫ | C=21|H=27|N=1|O=1
| molecular_weight = 309.445 g/mol
⚫ | bioavailability =
⚫ | protein_bound =
⚫ | metabolism =
⚫ | elimination_half-life =
⚫ | excretion =
⚫ | pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
⚫ | pregnancy_US = <!-- A / B / C / D / X -->
⚫ | pregnancy_category=
⚫ | legal_AU = <!-- Unscheduled / S2 / S3 / S4 / S5 / S6 / S7 / S8 / S9 -->
⚫ | legal_CA = <!-- / Schedule I, II, III, IV, V, VI, VII, VIII -->
⚫ | legal_UK = <!-- GSL / P / POM / CD / Class A, B, C -->
⚫ | legal_US = <!-- OTC / Rx-only / Schedule I, II, III, IV, V -->
⚫ | legal_status =
⚫ | routes_of_administration =
}} }}
'''Benproperine''' (]) is a ].<ref>{{cite journal | vauthors = Li Y, Zhong DF, Chen SW, Maeba I | title = Identification of some benproperine metabolites in humans and investigation of their antitussive effect | journal = Acta Pharmacologica Sinica | volume = 26 | issue = 12 | pages = 1519–26 | date = December 2005 | pmid = 16297353 | doi = 10.1111/j.1745-7254.2005.00212.x | doi-access = free }}</ref> It has been marketed in multiple countries in Central America and Europe, as the ] or ] salts in either tablet, ], or syrup form. Trade names include Blascorid in Italy and Sweden, Pectipront and Tussafug in Germany, and Pirexyl in Scandinavia. The recommended dosage for adults is 25 to 50 mg two to four times daily, and for children 25 mg once or twice daily. Adverse effects include dry mouth, dizziness, fatigue, and heartburn.<ref>{{cite book |isbn=0-8103-7177-4 |title=Drugs Available Abroad, 1st Edition |page=6 |date=1991 | vauthors = Schlesser JL |publisher=Derwent Publications Ltd.}}</ref>
'''Benproperine''' (]) is a ].
==Synthesis==
Patents:<ref>DK96113 idem Rubenstein K, {{Cite patent|GB|914008}} (1962 to Pharmacia AS). </ref><ref>Kurt Rubinstein, {{US patent|3117059}} (1964 to Aktieselskabet Pharmacia).</ref> Revised:<ref>Byoung Mog Kwon, et al. {{Cite patent|WO|2012064150}} (to Korea Research Institute of Bioscience and Biotechnology KRIBB).</ref> China:<ref></ref>]]


The base catalyzed ether formation between 2-Benzylphenol ('''1''') and ] ('''2''') gives 1-benzyl-2-(2-chloropropoxy)benzene ('''3'''). Displacement of the remaining halogen with piperidine completes the synthesis of ''benproperine'' ('''4''').


== References ==
{{reflist}}


{{Cough and cold preparations}} {{Cough and cold preparations}}


] ]
] ]
] ]
]




{{respiratory-system-drug-stub}} {{respiratory-system-drug-stub}}

]
Benproperine: Difference between revisions Add topic